Tanke Biosciences Corp announces addition of Chief Operating Officer and Board Member

Tanke Biosciences Corp announces addition of Chief Operating Officer and Board Member

Nevada --(BUSINESS WIRE)— January 9, 2024.  Tanke Biosciences Corp (OTC: TNBI) today announced that the Company is pleased to announce new management to the organization.

Tom Stien has been added as the new Chief Operating Officer (COO).  Tom Stein brings over two decades of experience in advisor and executive roles at both large and small public and private CPG companies such as Diageo, Edrington, and Bhang, and cutting-edge technology companies with YadaMedia, MRM Technology, and Plaier AI. Mr. Stein specializes in operating both business to business and direct to consumer companies and has led dynamic turnarounds into hyper growth organizations and proven track record across multiple industries. 

Tom has operated business in regulated industries such as adult beverage (Diageo, MillerCoors, Edrington) and THC/CBD (Bhang), covering private and public companies in those fields.  At Edrington, he took control of a troubled business unit and generated $24M over the next two years. Mr. Stein has also operated in MediaTech (YadaMedia), Deep Data Science AI (Plaier) and SaaS Technology Marketing (MRM Technology)  technology industries where he built a national distribution platform for new to world for business to business to consumer marketing technology.

“Through these experiences, Tom plans to combine his technology and CPG expertise to leverage advanced data analytics, machine learning, and AI-driven insights to create and deliver products that resonate deeply with modern consumers. This approach to product development will allow his team to respond swiftly to market trends and consumer preferences”, stated Caren Currier, CEO.

In addition, we have added Hortencia Torres, Esq., a seasoned tax attorney and financial manager, as a director.  Hortencia s has over 30 years of expertise and is the Managing Partner at Global Group—a conglomerate consisting of global tax, legal associates, and financial advisory partners. Hortencia has a vast client base high net worth individuals, corporations and family offices and oversees a current staff of 100+ employees. She holds a masters in taxation from Georgetown University and federal taxation and level 2 certificate from University of Virginia.

Ms. Torres has also operated in the verticals of pharmaceutical and insurance for international companies. She led and negotiated early sales and distribution channels for US based pharmaceutical companies and products, providing the architecture and infrastructure in  Central and South America.

“Hortencia’s financial experience, understanding of critical international markets and her vast network of client relationships will help to fuel the expansion of TNBI into new markets and audiences for each vertical focus. I am very excited to welcome her to our board and believe she will quickly make a major contribution”, stated Caren Currier, CEO.

About Tanke Biosciences Corp

Tanke Biosciences Corp (OTC: TNBI) is an emerging diversified investment vehicle focused on participating in and acquiring interests that are leading edge in their respective market niches, and that have expectations of enhancing shareholder values. Based in Nashville, Tennessee and Denton Texas, the management, advisors and the Board of the Company are focused on participating in and acquiring interests that are leading edge in their respective market niches, and that have expectations of enhancing shareholder values.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "should," and "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. All statements in this press release pertaining to our expectations relating to this acquisition constitute forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, but not limited to, the accuracy of our estimates regarding expenses, capital requirements and need for additional financing, our ability to operate our business and generate profits, decline in global financial markets and economic downturn resulting from the coronavirus COVID-19 global pandemic, business interruptions resulting from the coronavirus COVID-19 global pandemic, and general risk factors affecting the restaurant industry, including current economic climate, costs of labor and energy prices

These and other risks, assumptions and uncertainties are described in Item 1A (Risk Factors) of our most recent Annual Report on Form 10-K and in other documents that we file or furnish with the Securities and Exchange Commission, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. We expressly disclaim any current intention to update publicly any forward-looking statement after the distribution of this release, whether as a result of new information, future events, changes in assumptions or otherwise.